Why the study?
Is circulating CD34+ cell count associated with cardiovascular risk and metabolic syndrome?
Population
214 subjects at different levels of cardiovascular risk
Design
Cross-sectional
Authors
Loading...
CD34+ count may mark CV risk in metabolic syndrome; hypothesis-generating from cross-sectional data only.
Is circulating CD34+ cell count associated with cardiovascular risk and metabolic syndrome?
CD34+ cell count may serve as a surrogate marker for cardiovascular risk, particularly in patients with metabolic syndrome.
Gian Paolo Fadini (2006) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: